Search research articles
Contact Us
Filters
Showing results (51-60 of 129) with videos related to
Page
of 13
Sort By:
American Journal of Clinical Oncology
|
December 10, 1997
A phase II study of topotecan administered five times daily in patients with advanced gastric cancer
L B Saltz, G K Schwartz, D H Ilson, et al.
Cancer Clinical Trials
|
January 1, 1981
Pharmacokinetics of Malonato (1,2 diaminocyclohexane) platinum
D P Kelsen, P Ribaud, N Alcock, et al.
Cancer
|
November 14, 1997
9-Aminocamptothecin by 72-hour continuous intravenous infusion is inactive in the treatment of patients with 5-fluorouracil-refractory colorectal carcinoma
L B Saltz, N E Kemeny, W Tong, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 1, 1996
Neoadjuvant chemotherapy plus concurrent chemotherapy and high-dose radiation for squamous cell carcinoma of the esophagus: a preliminary analysis of the phase II intergroup trial 0122
B D Minsky, D Neuberg, D P Kelsen, et al.
British Journal of Cancer
|
May 20, 2004
Small-cell carcinoma of the gastrointestinal tract: a retrospective study of 64 cases
B Brenner, M A Shah, M Gonen, et al.
Oncology (Williston Park, N.Y.)
|
September 3, 1998
Irinotecan and cisplatin in upper gastrointestinal malignancies
P C Enzinger, D H Ilson, L B Saltz, et al.
Gastrointestinal Endoscopy
|
September 1, 1989
Diagnosis of recurrent upper gastrointestinal cancer at the surgical anastomosis by endoscopic ultrasound
C J Lightdale, J F Botet, D P Kelsen, et al.
Cancer
|
April 3, 1999
Phase II clinical trial of 13-cis-retinoic acid and interferon-alpha-2a in patients with advanced esophageal carcinoma
P C Enzinger, D H Ilson, L B Saltz, et al.
Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B
|
December 1, 1993
Interphase cytogenetics of gastric and esophageal adenocarcinomas
P H Rao, S Mathew, G Lauwers, et al.
American Journal of Clinical Oncology
|
February 1, 1990
Metastatic adenocarcinomas of unknown primary site. Prognostic variables and treatment results
S A Kambhu, D P Kelsen, J Fiore, et al.
Page
of 13
Search research articles
Search
Showing results (51-60 of 129) with videos related to
Sort By:
Page
of 13
American Journal of Clinical Oncology
|
December 10, 1997
A phase II study of topotecan administered five times daily in patients with advanced gastric cancer
L B Saltz, G K Schwartz, D H Ilson, et al.
Cancer Clinical Trials
|
January 1, 1981
Pharmacokinetics of Malonato (1,2 diaminocyclohexane) platinum
D P Kelsen, P Ribaud, N Alcock, et al.
Cancer
|
November 14, 1997
9-Aminocamptothecin by 72-hour continuous intravenous infusion is inactive in the treatment of patients with 5-fluorouracil-refractory colorectal carcinoma
L B Saltz, N E Kemeny, W Tong, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 1, 1996
Neoadjuvant chemotherapy plus concurrent chemotherapy and high-dose radiation for squamous cell carcinoma of the esophagus: a preliminary analysis of the phase II intergroup trial 0122
B D Minsky, D Neuberg, D P Kelsen, et al.
British Journal of Cancer
|
May 20, 2004
Small-cell carcinoma of the gastrointestinal tract: a retrospective study of 64 cases
B Brenner, M A Shah, M Gonen, et al.
Oncology (Williston Park, N.Y.)
|
September 3, 1998
Irinotecan and cisplatin in upper gastrointestinal malignancies
P C Enzinger, D H Ilson, L B Saltz, et al.
Gastrointestinal Endoscopy
|
September 1, 1989
Diagnosis of recurrent upper gastrointestinal cancer at the surgical anastomosis by endoscopic ultrasound
C J Lightdale, J F Botet, D P Kelsen, et al.
Cancer
|
April 3, 1999
Phase II clinical trial of 13-cis-retinoic acid and interferon-alpha-2a in patients with advanced esophageal carcinoma
P C Enzinger, D H Ilson, L B Saltz, et al.
Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B
|
December 1, 1993
Interphase cytogenetics of gastric and esophageal adenocarcinomas
P H Rao, S Mathew, G Lauwers, et al.
American Journal of Clinical Oncology
|
February 1, 1990
Metastatic adenocarcinomas of unknown primary site. Prognostic variables and treatment results
S A Kambhu, D P Kelsen, J Fiore, et al.
Page
of 13